Stay updated on Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.

Latest updates to the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe NIH announcement about terminology changes during a website transition no longer appears above the ClinicalTrials.gov error page.SummaryDifference1%

- Check20 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0 on the 403 Forbidden page.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner announces that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a terminology transition and links to updates and FAQs.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, effectively blocking access to the record. A minimal header with a Home link and a revision tag (Revision: v3.7.0) is shown.SummaryDifference16%

Stay in the know with updates to Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.